Company
Industrial biologics production platform
FlyPharma is commercialising a genetically enabled insect expression system for scalable, feed-grade biologics production.
FlyPharma is headquartered in Hong Kong, and operates a pilot production facility in Brisbane, Australia. The company integrates genetic engineering, automation, and proprietary process systems to enable cost-efficient biologics production at industrial scale.
Our Origin
Platform Foundation
FlyPharma operates a genetically enabled insect expression platform built on years of automated production development.
By combining proprietary strain access, automation engineering, and manufacturing discipline, the company converts biological expression into repeatable industrial output.
Founder & Leadership
Constant Tedder
Founder & CEO
Serial entrepreneur with three prior exits including Jagex (RuneScape), Dawn Energy, and The Hive. Brings experience in scaling technology platforms, industrial operations, and venture-backed growth.
Core team expertise across automation engineering, entomology, and biotechnology.
Multi-Product Platform
FlyPharma is not built around a single molecule or application.
The same production system supports:
- Immune-active proteins for animal health
- Natural pigments such as astaxanthin
- Additional bioactive compounds as the platform evolves
Each product strengthens the underlying platform, compounding value across genetics, process, and know-how.
Brisbane Pilot is operational
Automated platform:
- Genetically enabled BSF strains
- Automated rearing and handling systems
- Controlled expression cycles
- Data-driven yield monitoring
- Downstream biomass processing
This enables cost structures aligned with feed-grade deployment.
Pilot to Commercial
Commercialisation platform:
- Automated larval production
- Continuous expression cycles
- Fully automated rearing lines
- Process monitoring and optimisation
- Commercial-grade biomass processing
Commercial Pilots with Leading Poultry and Swine Producers are underway
Where the Advantage Lives
FlyPharma’s advantage is structural.
It sits across three interlocking layers:
Genetics
Automation
Know-How
These layers are inseparable. Replicating one without the others is insufficient.
Industrial Deployment Strategy
FlyPharma develops and scales production in stages.
We:
- Validate output under commercial operating conditions
- Integrate with established large scale animal producers and feed operators
- Expand capacity in line with verified demand
The focus is disciplined scale — ensuring durability, repeatability, and long-term supply.
Our Ambition
As the platform expands, biologics will be defined not by laboratory possibility, but by reliable, industrial-scale manufacturing.
Partner With FlyPharma
FlyPharma engages selectively.
If you are an integrated producer, feed manufacturer, strategic partner, or investor interested in deploying the next generation of biologics production at scale, we welcome the conversation.